Company News
Boston Scientific Shares Fall 10% on Watchman
Boston Scientific stock fell about 10% after CEO Mike Mahoney warned of flat US Watchman revenue and declining standalone procedures.
Company kept full‑year organic growth guidance of 6.5‑8% and Q2 gu
